Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

J Kimble Frazer, Kevin J Li, Paul J Galardy, Sherrie L Perkins, Anne Auperin, James R Anderson, Ross Pinkerton, Allen Buxton, Thomas G Gross, Jean Michon, Guy Leverger, Howard J Weinstein, Lauren Harrison, Bruce Shiramizu, Mathew J Barth, Stanton C Goldman, Catherine Patte, Mitchell S Cairo, J Kimble Frazer, Kevin J Li, Paul J Galardy, Sherrie L Perkins, Anne Auperin, James R Anderson, Ross Pinkerton, Allen Buxton, Thomas G Gross, Jean Michon, Guy Leverger, Howard J Weinstein, Lauren Harrison, Bruce Shiramizu, Mathew J Barth, Stanton C Goldman, Catherine Patte, Mitchell S Cairo

No abstract available

Keywords: central nervous system; B cell non-Hodgkin lymphoma; Burkitt lymphoma; paediatric; rituximab.

Conflict of interest statement

Conflict of Interest statement

Mitchell Cairo, MD is a consultant for Jazz Pharmaceuticals; Paul Galardy, MD received funding from Mission Therapeutics and has a financial interest in Abbott Laboratory.